US BANCORP \DE\ - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 139 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$1,0000.0%3090.0%0.00%
Q1 2021$1,000
-83.3%
309
-84.6%
0.00%
Q4 2020$6,000
+20.0%
2,0000.0%0.00%
Q3 2020$5,000
-81.5%
2,0000.0%0.00%
Q2 2020$27,000
+80.0%
2,0000.0%0.00%
Q1 2020$15,000
+15.4%
2,0000.0%0.00%
Q4 2019$13,000
+62.5%
2,0000.0%0.00%
Q3 2019$8,000
-20.0%
2,0000.0%0.00%
Q2 2019$10,000
-37.5%
2,0000.0%0.00%
Q1 2019$16,000
-71.9%
2,000
-80.5%
0.00%
Q4 2018$57,000
-37.4%
10,2530.0%0.00%
Q3 2018$91,000
+49.2%
10,253
+67.7%
0.00%
Q2 2018$61,000
+5.2%
6,1140.0%0.00%
Q1 2018$58,000
-48.7%
6,114
-19.6%
0.00%
Q4 2017$113,000
-5.8%
7,600
+24.3%
0.00%
Q3 2017$120,000
+757.1%
6,114
+511.4%
0.00%
Q2 2017$14,0001,0000.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders